Cursiefen Claus, Maruyama Kazuichi, Jackson David G, Streilein J Wayne, Kruse Friedrich E
Department of Ophthalmology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Cornea. 2006 May;25(4):443-7. doi: 10.1097/01.ico.0000183485.85636.ff.
To study the time course of angiogenesis and lymphangiogenesis in the cornea after a short inflammatory insult. This might be helpful for the timing of corneal transplantation in high-risk eyes.
The mouse model of suture-induced inflammatory corneal neovascularization was used. After placement of 3 interrupted 11-0 sutures into the corneal stroma of BALB/c mice (left in place for 14 days), corneas were excised 2, 3, 5, 7, 14, and 21 days as well as 1, 2, 3, 6, and 8 months after surgery. Hem- and lymphangiogenesis were evaluated using double immunohistochemistry of corneas with CD31/PECAM1 as panendothelial and LYVE-1 as lymphatic endothelial marker.
Both blood and lymphatic vessels grew into the cornea as early as day 2 after suture placement. The outgrowth was initially parallel. Hem- and lymphangiogenesis peaked around day 14. Thereafter, both vessel types started to regress. Regression of lymphatic vessels started earlier and was more pronounced than that of blood vessels. Whereas at 6 and 8 months (partly) perfused CD31+++/LYVE-1(-) blood vessels and (nonperfused) ghost vessels could still be observed, there were no CD31+/LYVE-1+++ lymphatic vessels detectable beyond 6 months after this short inflammation.
After a temporary inflammatory insult to the cornea, there is initially parallel outgrowth of both blood and lymphatic vessels. But thereafter, lymphatic vessels regress earlier than blood vessels and are completely regressed by 6 months. Earlier regression of pathologic corneal lymph versus blood vessels suggests that corneal graft survival in high-risk eyes might best be delayed for a prolonged interval following an inflammatory insult.
研究短期炎症刺激后角膜血管生成和淋巴管生成的时间进程。这可能有助于确定高危眼角膜移植的时机。
采用缝线诱导的炎症性角膜新生血管小鼠模型。在BALB/c小鼠角膜基质中置入3根间断的11-0缝线(保留14天)后,于术后2、3、5、7、14和21天以及1、2、3、6和8个月切除角膜。使用以CD31/PECAM1作为泛内皮标志物、LYVE-1作为淋巴管内皮标志物的角膜双重免疫组化法评估血管生成和淋巴管生成。
缝线置入后第2天,血管和淋巴管就开始长入角膜。最初二者生长平行。血管生成和淋巴管生成在第14天左右达到峰值。此后,两种血管类型均开始消退。淋巴管的消退开始得更早,且比血管的消退更明显。在6个月和8个月时,仍可观察到部分灌注的CD31+++/LYVE-1(-)血管和(未灌注的)残影血管,但在这种短期炎症后6个月以上,未检测到CD31+/LYVE-1+++淋巴管。
角膜受到短暂炎症刺激后,血管和淋巴管最初平行生长。但此后,淋巴管比血管更早消退,到6个月时完全消退。病理性角膜淋巴管比血管更早消退表明,高危眼角膜移植的最佳时机可能是在炎症刺激后延长一段时间再进行。